Journal of Evolving Stem Cell Research

Submit Manuscript

Journal of Evolving Stem Cell Research · ISSN 2574-4372 · Open Access Pub

About the Journal

A stem cell is defined by what it can still become. This journal publishes the work that establishes what a cell is, what it can become, and on what evidence each of those claims rests.

The Journal of Evolving Stem Cell Research is an international, peer-reviewed, open access journal published by Open Access Pub. Its subject is stem cell science in full: the biology of self-renewal and potency, the experimental systems that make those properties observable, the signals that direct differentiation and fate, and the translational work that carries laboratory findings toward clinical questions.

The territory the title names

Why the journal says evolving

Stem cell science moves on two fronts at once. One is the biology itself: how potency is established and held, how a cell commits to a lineage, and how those transitions can be read from molecular state and function. The other is the apparatus that makes such questions answerable — culture conditions, reporters, organoid and lineage-tracing systems, and the characterization standards that decide whether two laboratories are describing the same cell.

A journal whose subject is an evolving field carries an obligation to both. Findings matter, and so does the methodological work that makes findings comparable. The journal therefore publishes mechanism and model-building alongside the protocols, characterization and reporting practice that let a result travel beyond the bench that produced it.

That breadth is deliberate. Fundamental questions about identity, self-renewal and fate are the journal's core subject, not a preface to applied work; translational studies are read as one part of the same field rather than as its purpose. Each half is published on its own terms.

A protocol that cannot be reconstructed in another laboratory is not yet a result. Characterization, reporting and reproducibility are part of the science here, and are reviewed as such.

How claims are read

Registers of evidence

Stem cell research produces claims of several kinds, and each kind rests on a different sort of evidence. Editors read a manuscript first for the register its claims belong to, and ask that its conclusions stay within it.

Identity and self-renewal
What marks a cell as a stem cell, and how potency is established, maintained or resolved. Claims at this register rest on characterization: molecular state, marker profile, and functional assays of self-renewal and potency.
Experimental systems
Primary and pluripotent culture, organoids, reporters and lineage tracing. Claims at this register rest on what the system represents, on its stated limits, and on whether another group can reconstruct it from the methods as written.
Fate and differentiation
The signals, constraints and timing that settle which lineage a cell enters. Claims at this register rest on directed and repeated observation of the transition itself, rather than on an endpoint phenotype alone.
Carefully evaluated translation
Work that carries laboratory findings toward clinical questions. Claims at this register rest on the design that produced them: an early observational series describes what was seen in the participants it studied and frames a question that controlled study is designed to answer.

Readers and contributors

Who the journal is for

The journal is written for the researchers who work on these questions and for the people who have to interpret their results: cell and developmental biologists, bioengineers and materials scientists working on culture and scaffold systems, clinical investigators evaluating cell-based approaches, and the methodologists whose work decides whether results are comparable between laboratories.

Contributions are welcome from research groups in any country and at any point in a research program, from mechanism and model development through to carefully evaluated translational study.

Editorial responsibility

What the journal takes responsibility for

Assessing the work on its own evidence

Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. Those decisions remain independent of fees, services, memberships and roles.

Review by appropriate specialists

All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.

Keeping conclusions proportionate to the evidence

Editors ask that findings be reported for the design, sample and system that produced them. A result obtained in one model system is published as a result in that system, and an early clinical series is published as an early series. Published examples illustrate areas of the journal's scholarship; they do not define the boundary of its remit.

Research ethics in a sensitive field

The journal's policies align with COPE, ICMJE and ISSCR guidance. Research involving human embryonic stem cells, induced pluripotent stem cells derived from human subjects, or clinical application requires documented ethics committee approval and appropriate informed consent, and must comply with the applicable national and international guidelines. The editorial policies set these requirements out in full.

An open and attributable record

Articles are published open access under the Creative Commons Attribution 4.0 International License (CC BY 4.0), so that any reader may use and build on the work with attribution to its authors.

Menu